Gleaning For the World, Inc. – Trademark Portfolio
Entity Type: 54
Gleaning For the World, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include WINGS, GLEANING FOR THE WORLD, and WINGS A GLEANING PROGRAM. The owner is based in Concord, VA.
7539 Stage Rd
Concord, VA 24538
Showing of trademarks Trademarks
Trademark Classifications
Gleaning For the World, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Gleaning For the World, Inc. have?
Gleaning For the World, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does Gleaning For the World, Inc. file in?
Gleaning For the World, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Gleaning For the World, Inc.'s most well-known trademarks?
Gleaning For the World, Inc.'s registered trademark portfolio includes well-known marks such as WINGS, GLEANING FOR THE WORLD, and WINGS A GLEANING PROGRAM. These are among 3 currently registered trademarks in the portfolio.
What is Gleaning For the World, Inc.'s trademark registration success rate?
Gleaning For the World, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.